Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The CanACT and the ReACT trial
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- July 1, 2005
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1117 Public Health and Health Services (FoR)
- Arthritis & Rheumatology (Science Metrix)
published in
- Journal of Rheumatology Journal